Strides Shasun is currently trading at Rs. 938.75, up by 30.30 points or 3.34% from its previous closing of Rs. 908.45 on the BSE.
The scrip opened at Rs. 920.00 and has touched a high and low of Rs. 948.50 and Rs. 917.45 respectively. So far 36,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1259.00 on 03-Feb-2017 and a 52 week low of Rs. 848.50 on 24-May-2017.
Last one week high and low of the scrip stood at Rs. 948.50 and Rs. 901.00 respectively. The current market cap of the company is Rs. 8,401.00 crore.
The promoters holding in the company stood at 31.12%, while Institutions and Non-Institutions held 49.40% and 19.47% respectively.
Strides Shasun has received the Establishment Inspection Report (EIR) for its formulations facility (KRSG Gardens) in Bangalore, which was inspected by the USFDA in May 2017, thereby confirming the closure of the inspection. The KRS Gardens facility in Bangalore manufactures tablets, capsules, liquids, sachets, creams and ointments. The facility supports important current and future products for the US markets.
Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.
